Ilexsaponin ACAS# 108524-93-2 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 108524-93-2 | SDF | Download SDF |
| PubChem ID | 72163175 | Appearance | Powder |
| Formula | C36H56O11 | M.Wt | 664.83 |
| Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in methan | ||
| Chemical Name | (3S,4R,4aR,6aR,6bS,8aS,11R,12R,12aS,14aR,14bR)-3,12-dihydroxy-4,6a,6b,11,12,14b-hexamethyl-8a-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,11,12a,14,14a-tetradecahydropicene-4-carboxylic acid | ||
| SMILES | CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C(=O)O)O)C)C)C2C1(C)O)C)C(=O)OC6C(C(C(C(O6)CO)O)O)O | ||
| Standard InChIKey | AWFZJSUJFSUBQU-MOJLLMCOSA-N | ||
| Standard InChI | InChI=1S/C36H56O11/c1-18-9-14-36(30(44)47-28-26(41)25(40)24(39)20(17-37)46-28)16-15-32(3)19(27(36)35(18,6)45)7-8-21-31(2)12-11-23(38)34(5,29(42)43)22(31)10-13-33(21,32)4/h7,18,20-28,37-41,45H,8-17H2,1-6H3,(H,42,43)/t18-,20-,21-,22-,23+,24-,25+,26-,27-,28+,31-,32-,33-,34-,35-,36+/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Ilexsaponin A shows protective effects on ischemia-reperfusion-induced myocardial injury through anti-apoptotic pathway. |
| Targets | Bcl-2/Bax | Caspase | Akt |
Ilexsaponin A Dilution Calculator
Ilexsaponin A Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.5041 mL | 7.5207 mL | 15.0414 mL | 30.0829 mL | 37.6036 mL |
| 5 mM | 0.3008 mL | 1.5041 mL | 3.0083 mL | 6.0166 mL | 7.5207 mL |
| 10 mM | 0.1504 mL | 0.7521 mL | 1.5041 mL | 3.0083 mL | 3.7604 mL |
| 50 mM | 0.0301 mL | 0.1504 mL | 0.3008 mL | 0.6017 mL | 0.7521 mL |
| 100 mM | 0.015 mL | 0.0752 mL | 0.1504 mL | 0.3008 mL | 0.376 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- [D-Phe12,Leu14]-Bombesin
Catalog No.:BCC6020
CAS No.:108437-88-3
- [D-Phe12]-Bombesin
Catalog No.:BCC5844
CAS No.:108437-87-2
- FH535
Catalog No.:BCC1573
CAS No.:108409-83-2
- Fuligorubin A
Catalog No.:BCN1837
CAS No.:108343-55-1
- Noradrenaline bitartrate monohydrate
Catalog No.:BCC4810
CAS No.:108341-18-0
- Ganoderic acid D
Catalog No.:BCN2437
CAS No.:108340-60-9
- Geneticin, G-418 Sulfate
Catalog No.:BCC1202
CAS No.:108321-42-2
- Fmoc-D-Asn-OH
Catalog No.:BCC3083
CAS No.:108321-39-7
- 1,7-Bis(4-hydroxyphenyl)hept-1-en-3-one
Catalog No.:BCN1629
CAS No.:1083200-79-6
- 1,7-Bis(4-hydroxyphenyl)hept-6-en-3-ol
Catalog No.:BCN1630
CAS No.:1083195-05-4
- Cariprazine hydrochloride
Catalog No.:BCC1454
CAS No.:1083076-69-0
- A 987306
Catalog No.:BCC7732
CAS No.:1082954-71-9
- Ilexgenin A
Catalog No.:BCC9233
CAS No.:108524-94-3
- Eupahualin C
Catalog No.:BCN7234
CAS No.:108525-39-9
- 23S-hydroxy-11,15-dioxo-ganoderic acid DM
Catalog No.:BCN8131
CAS No.:1085273-49-9
- Pyridostatin
Catalog No.:BCC1875
CAS No.:1085412-37-8
- Lumichrome
Catalog No.:BCN7083
CAS No.:1086-80-2
-
4-Hydroxy-Teriflunomide
Catalog No.:BCC4734
CAS No.:
- GSK2126458
Catalog No.:BCC3884
CAS No.:1086062-66-9
- Mizolastine
Catalog No.:BCC4521
CAS No.:108612-45-9
- Purpureaside C
Catalog No.:BCN3865
CAS No.:108648-07-3
- Eupalinolide K
Catalog No.:BCN6199
CAS No.:108657-10-9
- Y 11
Catalog No.:BCC6206
CAS No.:1086639-59-9
- 1-O-Acetyl-6beta-O-Isobutyrylbritannilactone
Catalog No.:BCN1628
CAS No.:1087072-50-1
Ilexsaponin A attenuates ischemia-reperfusion-induced myocardial injury through anti-apoptotic pathway.[Pubmed:28182689]
PLoS One. 2017 Feb 9;12(2):e0170984.
The protective effects of Ilexsaponin A on ischemia-reperfusion-induced myocardial injury were investigated. Myocardial ischemia/reperfusion model was established in male Sprague-Dawley rats. Myocardial injury was evaluated by TTC staining and myocardial marker enzyme leakage. The in vitro protective potential of Ilexsaponin A was assessed on hypoxia/reoxygenation cellular model in neonatal rat cardiomyocytes. Cellular viability and apoptosis were evaluated by MTT and TUNEL assay. Caspase-3, cleaved caspase-3, bax, bcl-2, p-Akt and Akt protein expression levels were detected by western-blot. Ilexsaponin A treatment was able to attenuate the myocardial injury in ischemia/reperfusion model by reducing myocardial infarct size and lower the serum levels of LDH, AST and CK-MB. The in vitro study also showed that Ilexsaponin A treatment could increase cellular viability and inhibit apoptosis in hypoxia/reoxygenation cardiomyocytes. Proapoptotic proteins including caspase-3, cleaved caspase-3 and bax were significantly reduced and anti-apoptotic protein bcl-2 was significantly increased by Ilexsaponin A treatment in hypoxia/reoxygenation cardiomyocytes. Moreover, Ilexsaponin A treatment was able to increase the expression levels of p-Akt in hypoxia/reoxygenation cellular model and myocardial ischemia/reperfusion animal model. Coupled results from both in vivo and in vitro experiments indicate that Ilexsaponin A attenuates ischemia-reperfusion-induced myocardial injury through anti-apoptotic pathway.
Two new triterpene saponins from the anti-inflammatory saponin fraction of Ilex pubescens root.[Pubmed:18649303]
Chem Biodivers. 2008 Jul;5(7):1369-76.
The saponin fraction from the ethanolic extracts of the root of Ilex pubescens Hook. et Arn. (Ilexaceae) was found to exhibit potent anti-inflammatory effects on carrageenan-induced paw edema in rats. Two novel triterpene saponins, pubescenosides C and D (1 and 2, resp.), together with five known saponins were isolated from this saponin fraction. The structures of 1 and 2 were elucidated as (20beta)-3-O-[beta-D-glucopyranosyl-(1-->2)-beta-D-xylopyranosyl]ursa-12,18-dien- 28-oic acid 28-O-beta-D-glucopyranosyl ester, and (20beta)-3-O-[alpha-L-rhamnopyranosyl-(1-->2)-beta-D-glucopyranosyl-(1-->2)-beta- D-xylopyranosyl]ursa- 12,18-dien-28-oic acid 28-O-beta-D-glucopyranosyl ester, respectively, on the basis of chemical and spectroscopic data. Five known saponins isolated from the saponin fraction were identified as ilexsaponin B(1), B(2), B(3), A(1), and chikusetsusaponin IV(a).
